Cargando…
CCNB2, TOP2A, and ASPM Reflect the Prognosis of Hepatocellular Carcinoma, as Determined by Weighted Gene Coexpression Network Analysis
BACKGROUND: Hepatocellular carcinoma (HCC) is characterized by increased mortality and poor prognosis. We aimed to identify potential prognostic markers by weighted gene coexpression network analysis (WGCNA), to assist clinical outcome prediction and improve treatment decisions for HCC patients. MET...
Autores principales: | Zeng, Yuping, He, He, Zhang, Yu, Wang, Xia, Yang, Lidan, An, Zhenmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333053/ https://www.ncbi.nlm.nih.gov/pubmed/32685486 http://dx.doi.org/10.1155/2020/4612158 |
Ejemplares similares
-
CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis
por: Yang, Zhiqiang, et al.
Publicado: (2021) -
CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020) -
CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a
bioinformatics study
por: Li, An-hai, et al.
Publicado: (2022) -
Role of CCNB1, CENPF, and neutrophils in lung cancer diagnosis and prognosis
por: Tan, Feixiang, et al.
Publicado: (2023) -
ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
por: Tan, Siyou, et al.
Publicado: (2022)